| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/11/2002 | US20020090384 Anti-irritant compositions containing a cyclic nucleotide |
| 07/11/2002 | US20020090379 Poviding self-protein analog by molecular biological means by substitution of one or more peptide fragments of self-protein by corresponding number of peptides known to contain immunodominant foreign T-cell epitopes |
| 07/11/2002 | US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof |
| 07/11/2002 | US20020090371 Orally or enterally administering to the mammal an effective immunosuppressive dose of a plant material derived from a plant transformant capable of producing antigen or an immunosuppressive fragment or its derivative |
| 07/11/2002 | US20020090368 Therapeutic uses of bactericidal/permeability increasing (BPI) protein products |
| 07/11/2002 | DE10064195A1 Verwendung einer Zusammensetzung zur Stimulation des Nervenwachstums, zur Inhibition der Narbengewebsbildung und/oder Reduktion eines Sekundärschadens Use of a composition for the stimulation of nerve growth, to inhibition of scar tissue formation and / or reduction of secondary damage |
| 07/11/2002 | CA2434136A1 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | CA2434124A1 N(phenylsulphonyl)glycine derivatives and their therapeutic use |
| 07/11/2002 | CA2433559A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | CA2433552A1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/11/2002 | CA2433225A1 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 07/11/2002 | CA2433125A1 Medicament containing a polyamine as an active substance |
| 07/11/2002 | CA2432853A1 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 07/11/2002 | CA2432409A1 Tropolone derivative |
| 07/10/2002 | EP1221615A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
| 07/10/2002 | EP1221441A2 LTA4 Hydrolase inhibitors |
| 07/10/2002 | EP1221315A1 Ophthalmic adhesive preparations for percutaneous absorption |
| 07/10/2002 | EP1220948A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 07/10/2002 | EP1220947A2 50 human secreted proteins |
| 07/10/2002 | EP1220942A1 41 human secreted proteins |
| 07/10/2002 | EP1220922A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 07/10/2002 | EP1220918A2 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use |
| 07/10/2002 | EP1220906A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 07/10/2002 | EP1220900A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 07/10/2002 | EP1220865A1 43 human secreted proteins |
| 07/10/2002 | EP1220863A1 Purine derivatives |
| 07/10/2002 | EP1220862A1 Purine derivatives |
| 07/10/2002 | EP1220852A1 Substituted diazepans |
| 07/10/2002 | EP1220845A1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors |
| 07/10/2002 | EP1220844A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 07/10/2002 | EP1220840A2 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 07/10/2002 | EP1220839A2 Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors |
| 07/10/2002 | EP1220836A2 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 07/10/2002 | EP1220831A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 07/10/2002 | EP1220699A1 Medicament pack |
| 07/10/2002 | EP1220690A2 Injection vehicle for polymer-based formulations |
| 07/10/2002 | EP1220684A2 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/10/2002 | EP1220682A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 07/10/2002 | EP1220661A2 Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid |
| 07/10/2002 | EP1220657A1 Liposome encapsulated silver salt compositions |
| 07/10/2002 | CN1358228A Polynucleotide and deduced amino acid sequences from stromal cells |
| 07/10/2002 | CN1358195A Inhibitors of integrin alpha V beta 6 |
| 07/10/2002 | CN1358193A Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/10/2002 | CN1358192A 嘌呤衍生物 Purine derivatives |
| 07/10/2002 | CN1358191A N-pyrazole A2A receptor agonists |
| 07/10/2002 | CN1358190A Propargyl phenyl ether A2A receptor agonists |
| 07/10/2002 | CN1358178A Pharmaceutical compounds |
| 07/10/2002 | CN1358175A Pyrimidinone compounds |
| 07/10/2002 | CN1358094A Method for treating chronic pain using MEK inhibitors |
| 07/10/2002 | CN1358093A Decursinol or derivative thereof as analgesic agent |
| 07/10/2002 | CN1357358A Blood circulation activating and pain stopping ointment for treating bone injury and its prepn process |
| 07/10/2002 | CN1357335A Bressed pain-relieving medicine powder |
| 07/10/2002 | CN1357333A Application of hydrochloric acid in preparing medicine for tumor |
| 07/10/2002 | CN1357324A Loselofen sodium injection and its prepn |
| 07/10/2002 | CN1357321A Inflammation and red spot reducing method |
| 07/10/2002 | CN1357320A Taurine chewing gum and its making process |
| 07/10/2002 | CN1087346C RANTFS peptide and fragments for treatment of inflammation, and compositions with them |
| 07/09/2002 | US6417393 Treatment of sickle-cell anemia, brain edema from tumors or ischemia, diarrhea, and glaucoma; hypotensive, wound healing, antiinflammatory and antiallergen agents |
| 07/09/2002 | US6417371 Process for preparing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-acetic acid |
| 07/09/2002 | US6417334 Antagonists to chaperonin 10 |
| 07/09/2002 | US6417227 Methods of delivery of cetyl myristoleate |
| 07/09/2002 | US6417219 Enzyme inhibitors and osteoarthritis |
| 07/09/2002 | US6417218 Substituted imidazoles, their preparation and use |
| 07/09/2002 | US6417215 Calcilytic compounds |
| 07/09/2002 | US6417205 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 07/09/2002 | US6417197 Prodrugs formed with esterification and acidification |
| 07/09/2002 | US6417192 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 07/09/2002 | US6417188 Arylalkanoylpyridazines |
| 07/09/2002 | US6417186 Substituted-phenyl ketone derivatives as IP antagonists |
| 07/09/2002 | US6416991 Genetic engineered protein |
| 07/09/2002 | US6416794 Methods and compositions for treating cataracts using substances derived from yeast or saltbush |
| 07/09/2002 | CA2217455C New substituted derivatives, of biphenyl or phenylpiridine, their preparation process and the pharmaceutical compositions that contain them |
| 07/09/2002 | CA2211444C New benzimidazol, benzoxazol and benzothiazol derivitives, the procedure for preparing them and the pharmaceutical compositions which contain them. |
| 07/09/2002 | CA2133218C Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase |
| 07/09/2002 | CA2094137C Novel hydroxamic acid and n-hydroxyurea derivatives and their use |
| 07/04/2002 | WO2002052270A2 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 07/04/2002 | WO2002052267A1 A method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor |
| 07/04/2002 | WO2002052036A2 Identification of modulators of dham-kinase and inflammatory diseases |
| 07/04/2002 | WO2002051999A1 Novel atopic dermatitis-associated gene and proteins |
| 07/04/2002 | WO2002051983A2 Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2002 | WO2002051871A2 Anti-cd28 antibody |
| 07/04/2002 | WO2002051848A2 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors |
| 07/04/2002 | WO2002051835A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 07/04/2002 | WO2002051831A1 Oxybenzamides derivatives as factor xa inhibitors |
| 07/04/2002 | WO2002051821A1 Therapeutic compounds |
| 07/04/2002 | WO2002051814A1 Benzoylpyridazines |
| 07/04/2002 | WO2002051807A1 Compounds |
| 07/04/2002 | WO2002051805A1 Indole derivatives as ligands of thyroid receptors |
| 07/04/2002 | WO2002051442A1 Concomitant drugs |
| 07/04/2002 | WO2002051440A1 Combination drugs |
| 07/04/2002 | WO2002051438A2 Use of repulsive guidance molecule (rgm) and its modulators |
| 07/04/2002 | WO2002051435A2 New therapeutic uses of smr1 peptides |
| 07/04/2002 | WO2002051434A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 07/04/2002 | WO2002051429A2 Use of a composition for the stimulation of nerve growth, the inhibition of scar tissue formation, the reduction of secondary damage and/or the accumulation of macrophages |
| 07/04/2002 | WO2002051424A1 Drugs against articular failure |
| 07/04/2002 | WO2002051405A1 New clinical treatment |
| 07/04/2002 | WO2002051397A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 07/04/2002 | WO2002051389A2 Aerogel powder comprising therapeutic agents |
| 07/04/2002 | WO2002014317A3 Substituted pyrazoles |
| 07/04/2002 | WO2002012346A8 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |